Nexstem is now Anthriq. A new name that reflects what we’ve grown into: building foundational infrastructure for human-aware technology. Same DNA. Clearer direction. Read more in our Press Release: anthriq.com/post/nexstem-is-…

Train on one subject. Deploy on another. No recalibration.That's the dream in neurotech & neural geometry keeps breaking it. 𝐖𝐡𝐚𝐭'𝐬 𝐭𝐡𝐞 𝐫𝐞𝐚𝐥 𝐛𝐥𝐨𝐜𝐤𝐞𝐫 𝐟𝐨𝐫 𝐜𝐫𝐨𝐬𝐬-𝐬𝐮𝐛𝐣𝐞𝐜𝐭 𝐭𝐫𝐚𝐧𝐬𝐟𝐞𝐫? Vote👇 #Neurotech #BCI #Biosignals #Anthriq

Blood pressure checks happen at every village health centre in India. Brain health checks don't. There's no scientific reason for that gap — only an infrastructure one. We already have FDA-approved drugs that slow Alzheimer's progression. Lecanemab. Donanemab. They work — but only in early-stage patients. By the time most people receive a diagnosis, the treatment window has already closed. The bottleneck isn't the science. It's the access. A 2-hour cognitive battery needs a specialist and a clinic. That combination doesn't exist where the disease burden is highest. Project Brain Aging is built for that gap. Wireless, dry EEG. No gel. No specialist. A brain-age score in four minutes — at a primary health centre, a school, a community screening camp. Cognitive screening as routine as a blood pressure check. That's the target. Swipe through -> Tag someone working on this problem. #BrainHealth #HealthcareAccess #AlzheimersAwareness #Neurotechnology #EEG #DeepTech #CognitiveCare #Anthriq

What's the first thing that goes when you're sleep-deprived? #Neuroscience #GlymphaticSystem #SleepScience #BrainHealth #Neurotech

𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐫𝐞𝐚𝐝 𝐈𝐬𝐬𝐮𝐞 #𝟑𝟖 𝐨𝐟 𝐍𝐞𝐮𝐫𝐨𝐭𝐞𝐜𝐡 𝐏𝐮𝐥𝐬𝐞? 𝐒𝐢𝐠𝐧𝐚𝐥𝐬, 𝐒𝐭𝐫𝐨𝐤𝐞𝐬 & 𝐒𝐨𝐯𝐞𝐫𝐞𝐢𝐠𝐧 𝐂𝐚𝐩𝐢𝐭𝐚𝐥: 𝐓𝐡𝐞 𝐍𝐞𝐰 𝐍𝐞𝐮𝐫𝐨𝐭𝐞𝐜𝐡 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 𝐂𝐲𝐜𝐥𝐞. This month marks a major shift in neurotech financing, with capital flowing aggressively into mental health, implantable neuromodulation, and next-generation BCIs. On the clinical front, Mobia Medical's $150M Nasdaq IPO, CorTec's first-in-human implantable BCI results for stroke recovery, and EpiNeuron, LLC's FDA clearance highlight the growing maturity of therapeutic neurotechnology. Capital continues to scale across the ecosystem. Neuralink secured sovereign backing from Oman's OIA, BlueWind Medical raised $47.8M for bladder neuromodulation, while SonoMind, Ampa, and Nexstim attracted significant investment to advance non-invasive neuromodulation therapies. Meanwhile, a landmark partnership between MintNeuro and Motif Neurotech signals growing convergence between advanced neuroelectronics and therapeutic BCIs, as companies race to build smaller, more scalable neural implants. This issue's case study spotlight features Subsense Inc., a company pursuing one of neurotech's boldest ideas yet: a bidirectional brain-computer interface delivered through engineered nanoparticles and a nasal spray—without surgery. 🔗 Read the full issue: shorturl.at/Qd3ep #NeurotechPulse #Neurotech #Neuroscience #BCI #Anthriq #MentalHealthTech #DigitalHealth

𝐁𝐮𝐢𝐥𝐝𝐢𝐧𝐠 𝐚 𝐟𝐞𝐥𝐥𝐨𝐰𝐬𝐡𝐢𝐩 𝐟𝐨𝐫 𝐧𝐞𝐮𝐫𝐨𝐬𝐜𝐢𝐞𝐧𝐜𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐢𝐧 𝐈𝐧𝐝𝐢𝐚. 𝐖𝐡𝐚𝐭 𝐭𝐡𝐞 𝐝𝐞𝐬𝐢𝐠𝐧 𝐚𝐜𝐭𝐮𝐚𝐥𝐥𝐲 𝐭𝐚𝐤𝐞𝐬. This session brought together researchers, students, and program designers to work through what it genuinely takes to structure a fellowship for applied neuroscience research. We got into the questions that most program designs leave unanswered: how to separate those who identify problems from those who solve them, how to structure mega projects so part-time fellows can contribute without compromising output, and what it costs — in budget and in trust — to collect data responsibly. What became clear is how much programme design shapes research outcomes. A poorly structured fellowship doesn't just slow things down — it determines what questions get asked, and by whom. A grounded, detailed exchange shaped by the people closest to the problems. A big thank you to everyone who joined and contributed to the conversation. 𝗪𝗮𝗻𝘁 𝘁𝗼 𝗯𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗡𝗲𝘂𝗿𝗼𝘁𝗲𝗰𝗵 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆? Join the waitlist →  lnkd.in/dg7vE-fR #Neurotech #DeepTech #Healthtech #ResearchFellowship #Neuroscience #Bangalore

Anthriq is actively recruiting across multiple engineering positions, with an immediate focus on: • Principal Compiler Engineer (10 years) • Lead RTL Engineer (10 years) — we're hiring for multiple positions These roles demand people who are precision-driven, believe in high-impact work, and take real ownership of what they build. If that's how you operate, we'd like to talk. Apply for open roles at: anthriq.com/careers #HiringAlert #RTLEngineer #ChipDesign #VLSI #Complier #JoinOurTeam #Anthriq